
Heron Therapeutics HRTX
€ 1.09
0.79%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Heron Therapeutics EV 2011-2026 | HRTX
EV Jährlich Heron Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 557 M | 554 M | 428 M | 138 M | 1.59 B | 1.79 B | 2.03 B | 1.19 B | 551 M | 639 M | 151 M | 126 M | 144 M | 19.4 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.03 B | 19.4 M | 708 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Aclaris Therapeutics
ACRS
|
192 M | $ 2.63 | -2.05 % | $ 203 M | ||
|
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
726 M | $ 211.71 | -0.74 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.27 | 1.87 % | $ 7.87 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.11 B | $ 1.89 | -3.08 % | $ 482 M | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | ||
|
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
-6.64 B | $ 99.5 | -0.58 % | $ 27.2 B | ||
|
BioDelivery Sciences International
BDSI
|
445 M | - | -4.8 % | $ 255 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
2 B | $ 28.01 | 2.47 % | $ 1.36 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 4.41 | -6.57 % | $ 9.6 B | ||
|
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | ||
|
Catalyst Biosciences
CBIO
|
38.1 M | $ 11.04 | 0.91 % | $ 727 M | ||
|
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B | ||
|
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
10.2 B | $ 11.09 | -5.62 % | $ 717 M | ||
|
BioVie
BIVI
|
-12.6 M | $ 1.3 | -4.07 % | $ 1.92 M | ||
|
Axon Enterprise
AXON
|
41.5 B | $ 617.73 | -0.51 % | $ 46.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-15.2 M | $ 2.66 | -6.01 % | $ 16.7 M | ||
|
AstraZeneca PLC
AZN
|
57.7 B | $ 95.28 | 0.13 % | $ 96.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | ||
|
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
3.22 B | $ 9.28 | -0.16 % | $ 1.51 B | ||
|
bluebird bio
BLUE
|
270 M | - | - | $ 546 M | ||
|
Biogen
BIIB
|
28.3 B | $ 185.85 | -0.57 % | $ 27.1 B | ||
|
Abeona Therapeutics
ABEO
|
184 M | $ 5.06 | -3.07 % | $ 108 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
169 M | $ 1.46 | - | $ 16.7 M | ||
|
Cellectis S.A.
CLLS
|
109 M | $ 4.5 | -1.1 % | $ 116 M |